Tg(TcraY4,TrcbY4)F2025Tdsc
Transgene Detail
|
Symbol: |
Tg(TcraY4,TrcbY4)F2025Tdsc |
Name: |
transgene insertion F2025, Todd Schell |
MGI ID: |
MGI:6391061 |
Synonyms: |
TCR-IV |
Transgene: |
Tg(TcraY4,TrcbY4)F2025Tdsc Location: unknown
|
Alliance: |
Tg(TcraY4,TrcbY4)F2025Tdsc page
|
|
|
Transgene Type: |
|
Transgenic (Inserted expressed sequence) |
Mutation: |
|
Insertion
|
|
|
Tg(TcraY4,TrcbY4)F2025Tdsc expresses
2 genes
Transgene expresses:
Organism |
Expressed Gene |
Note |
mouse |
Tcra (MGI:98553) |
expresses Valpha15-Jalpha12 |
mouse |
Tcrb (MGI:98578) |
expresses Vbeta9-Jbeta2.5 |
|
|
|
Mutation details: The transgenic construct contains sequences from the alpha and beta-chains of the T cell receptor (TCR) from the SV40 large tumor antigen epitope IV-specific cytotoxic T lymphocyte clone Y-4. The TCR subunits express Vbeta9-Jbeta2.5 and Valpha15-Jalpha12.
(J:142961)
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 1 strain available
Cell Lines: 0 lines available
|
|
Original: |
J:142961 Tatum AM, et al., CD8+ T cells targeting a single immunodominant epitope are sufficient for elimination of established SV40 T antigen-induced brain tumors. J Immunol. 2008 Sep 15;181(6):4406-17 |
All: |
1 reference(s) |
|